FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 140 filers reported holding FATE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $587,448 | +62.0% | 179,100 | +4.7% | 0.00% | – |
| Q3 2023 | $362,520 | -55.5% | 171,000 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $813,960 | -14.9% | 171,000 | +1.9% | 0.00% | 0.0% |
| Q1 2023 | $956,460 | -49.4% | 167,800 | -10.5% | 0.00% | 0.0% |
| Q4 2022 | $1,890,866 | -54.0% | 187,400 | +2.2% | 0.00% | -66.7% |
| Q3 2022 | $4,108,000 | -8.8% | 183,300 | +0.9% | 0.00% | 0.0% |
| Q2 2022 | $4,503,000 | -35.7% | 181,700 | +0.6% | 0.00% | -25.0% |
| Q1 2022 | $7,002,000 | -28.6% | 180,600 | +7.8% | 0.00% | -33.3% |
| Q4 2021 | $9,800,000 | -0.5% | 167,500 | +0.8% | 0.01% | 0.0% |
| Q3 2021 | $9,851,000 | -31.4% | 166,200 | +0.5% | 0.01% | -33.3% |
| Q2 2021 | $14,355,000 | +9.2% | 165,400 | +3.8% | 0.01% | 0.0% |
| Q1 2021 | $13,143,000 | -8.0% | 159,400 | +1.5% | 0.01% | -10.0% |
| Q4 2020 | $14,285,000 | +153.6% | 157,100 | +11.5% | 0.01% | +150.0% |
| Q3 2020 | $5,632,000 | +21.7% | 140,900 | +4.4% | 0.00% | 0.0% |
| Q2 2020 | $4,628,000 | +77.7% | 134,900 | +15.0% | 0.00% | +33.3% |
| Q1 2020 | $2,605,000 | +17.5% | 117,300 | +3.5% | 0.00% | +50.0% |
| Q4 2019 | $2,217,000 | +28.7% | 113,300 | +2.2% | 0.00% | 0.0% |
| Q3 2019 | $1,722,000 | -11.7% | 110,900 | +15.4% | 0.00% | 0.0% |
| Q2 2019 | $1,951,000 | +18.1% | 96,100 | +2.2% | 0.00% | 0.0% |
| Q1 2019 | $1,652,000 | +45.2% | 94,000 | +6.0% | 0.00% | +100.0% |
| Q4 2018 | $1,138,000 | -19.1% | 88,700 | +2.7% | 0.00% | -50.0% |
| Q3 2018 | $1,407,000 | +68.9% | 86,400 | +17.6% | 0.00% | +100.0% |
| Q2 2018 | $833,000 | – | 73,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $197,709,000 | 22.51% |
| Redmile Group, LLC | 12,957,222 | $758,127,000 | 17.24% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $60,690,000 | 6.28% |
| Casdin Capital, LLC | 3,400,000 | $198,934,000 | 5.61% |
| Ally Bridge Group (NY) LLC | 270,000 | $15,798,000 | 5.52% |
| DAFNA Capital Management LLC | 372,160 | $21,775,000 | 5.48% |
| Tri Locum Partners LP | 142,032 | $8,310,000 | 3.27% |
| Kynam Capital Management, LP | 95,561 | $5,591,000 | 2.99% |
| Artal Group S.A. | 1,800,000 | $105,318,000 | 2.86% |
| Bellevue Group AG | 3,775,736 | $220,918,000 | 2.28% |